138 related articles for article (PubMed ID: 32431518)
1. SCAMP3 Promotes Glioma Proliferation and Indicates Unfavorable Prognosis via Multiple Pathways.
Li C; Zhang Z; Lv P; Zhan Y; Zhong Q
Onco Targets Ther; 2020; 13():3677-3687. PubMed ID: 32431518
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Stromal Antigen 2 is a Potential Unfavorable Prognostic Factor for High-Grade Glioma.
Shi H; Luo K; Huang W
Onco Targets Ther; 2020; 13():8723-8734. PubMed ID: 32943880
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma.
Zhang X; Sheng J; Zhang Y; Tian Y; Zhu J; Luo N; Xiao C; Li R
Oncotarget; 2017 Dec; 8(65):109247-109257. PubMed ID: 29312605
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Evaluation of Endocytosis-Associated Protein SCAMP3 in Hepatocellular Carcinoma.
Zhou A; Liu H; Tang B
Pharmgenomics Pers Med; 2020; 13():415-426. PubMed ID: 33116758
[TBL] [Abstract][Full Text] [Related]
5. SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR-MAPK p38 signaling pathway.
Kang L; Zhang ZH; Zhao Y
Am J Transl Res; 2020; 12(12):7870-7884. PubMed ID: 33437366
[TBL] [Abstract][Full Text] [Related]
6. SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways.
Acevedo-Díaz A; Morales-Cabán BM; Zayas-Santiago A; Martínez-Montemayor MM; Suárez-Arroyo IJ
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681787
[TBL] [Abstract][Full Text] [Related]
7. High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients.
Tian X; Wang Y; Ding X; Cheng W
J Neurosurg Sci; 2022 Jun; 66(3):228-233. PubMed ID: 31738028
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis and RNA-Sequencing of SCAMP3 Expression and Correlated Gene Regulation in Hepatocellular Carcinoma.
Han SS; Feng ZQ; Liu R; Ye J; Cheng WW; Bao JB
Onco Targets Ther; 2020; 13():1047-1057. PubMed ID: 32099407
[TBL] [Abstract][Full Text] [Related]
9. Tac2-N Promotes Glioma Proliferation and Indicates Poor Clinical Outcomes.
Dou Y; Xu H; Wu X; Liu P
Tohoku J Exp Med; 2021 Nov; 255(3):247-256. PubMed ID: 34840225
[TBL] [Abstract][Full Text] [Related]
10. SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma.
Venugopalan A; Lynberg M; Cultraro CM; Nguyen KDP; Zhang X; Waris M; Dayal N; Abebe A; Maity TK; Guha U
Oncogene; 2021 May; 40(18):3331-3346. PubMed ID: 33850265
[TBL] [Abstract][Full Text] [Related]
11. High expression of mitogen-activated and stress-activated protein kinase 1 indicates poor prognosis in patients with glioma.
Li H; Zhao C; Xu M; Yin M
Neuroreport; 2018 Oct; 29(15):1249-1255. PubMed ID: 30020192
[TBL] [Abstract][Full Text] [Related]
12. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
13. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.
Men D; Liang Y; Chen L
Cancer Epidemiol; 2014 Apr; 38(2):152-6. PubMed ID: 24559637
[TBL] [Abstract][Full Text] [Related]
15. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
[TBL] [Abstract][Full Text] [Related]
16. Secretory Carrier Membrane Protein 3 Interacts with 3A Viral Protein of Enterovirus and Participates in Viral Replication.
Lu JY; Brewer G; Li ML; Lin KZ; Huang CC; Yen LC; Lin JY
Microbiol Spectr; 2021 Sep; 9(1):e0047521. PubMed ID: 34378951
[TBL] [Abstract][Full Text] [Related]
17. Yippee Like 1 Suppresses Glioma Progression and Serves as a Novel Prognostic Factor.
Li W; Huang W; Wu K; Long Y
Tohoku J Exp Med; 2022 Feb; 256(2):141-150. PubMed ID: 35185081
[TBL] [Abstract][Full Text] [Related]
18. SCAMP3 negatively regulates epidermal growth factor receptor degradation and promotes receptor recycling.
Aoh QL; Castle AM; Hubbard CH; Katsumata O; Castle JD
Mol Biol Cell; 2009 Mar; 20(6):1816-32. PubMed ID: 19158374
[TBL] [Abstract][Full Text] [Related]
19. Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.
Zhou X; Xie S; Wu S; Qi Y; Wang Z; Zhang H; Lu D; Wang X; Dong Y; Liu G; Yang D; Shi Q; Bian W; Yu R
Neuro Oncol; 2017 Nov; 19(12):1628-1639. PubMed ID: 28575494
[TBL] [Abstract][Full Text] [Related]
20. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
